HEDIMED Consortium meeting will take place on April (8^th) 9^th-11^th, 2025 in Siena.

The HEDIMED (Human Exposomic Determinants of Immune Mediated diseases) project aims to identify the environmental causes behind type 1 diabetes, celiac disease, allergies and asthma.

In HEDIMED altogether 22 academic and industrial partners from 13 different countries join their multidisciplinary and supplementary forces to identify exposomic determinants which are driving the epidemic of immune-mediated diseases.

Prof. Francescco Dotta is the principal investigator for the research unit of the University of Siena.